Ekso Bionics Holdings Inc (OQ:EKSO)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 1414 Harbour Way S Ste 1201
RICHMOND CA 94804-3628
Tel: 1-212-8671768
Website: https://ir.eksobionics.com
IR: See website
<
Key People
Steven A. Sherman
Executive Chairman of the Board
Jack Peurach
President, Chief Executive Officer, Director
John F. Glenn
Chief Financial Officer, Secretary
William R. Shaw
Chief Commercial Officer
   
Business Overview
Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.
Financial Overview
For the nine months ended 30 September 2019, Ekso Bionics Holdings Inc revenues increased 27% to $10.2M. Net loss decreased 59% to $9.4M. Revenues reflect EksoHealth segment increase from $2.1M to $5.7M, EksoWorks segment increase from $396K to $1.2M, United States segment increase of 34% to $6.7M, All other segment increase of 15% to $3.5M.
Employees: 82 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $37.25M as of Sep 30, 2019
Annual revenue (TTM): $13.49M as of Sep 30, 2019
EBITDA (TTM): -$18.08M as of Sep 30, 2019
Net annual income (TTM): -$13.54M as of Sep 30, 2019
Free cash flow (TTM): -$19.57M as of Sep 30, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 74,952,547 as of Oct 25, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization